Exam 20: Autoimmune Hemolytic Anemias
Exam 1: Red Blood Cells and Platelet Preservation: Historical Perspectives and Current Trends44 Questions
Exam 2: Basic Genetics40 Questions
Exam 3: Fundamentals of Immunology68 Questions
Exam 4: Concepts in Molecular Biology44 Questions
Exam 5: The Antiglobulin Test45 Questions
Exam 6: The Abo Blood Group System70 Questions
Exam 7: The RH Blood Group System51 Questions
Exam 8: Blood Group Terminology and the Other Blood Groups214 Questions
Exam 9: Detection and Identification of Antibodies76 Questions
Exam 10: Pre-Transfusion Testing63 Questions
Exam 11: Overview of the Routine Blood Bank Laboratory36 Questions
Exam 12: Other Technologies and Automation20 Questions
Exam 13: Donor Screening and Component Preparation33 Questions
Exam 14: Apheresis57 Questions
Exam 15: Transfusion Therapy97 Questions
Exam 17: Cellular Therapy99 Questions
Exam 18: Transfusion-Transmitted Diseases41 Questions
Exam 19: Hemolytic Disease of the Fetus and Newborn55 Questions
Exam 20: Autoimmune Hemolytic Anemias66 Questions
Exam 21: The Hla System46 Questions
Exam 22: Relationship Testing25 Questions
Exam 23: Quality Management20 Questions
Exam 24: Transfusion Safety and Federal Regulatory Requirements26 Questions
Exam 24: Utilization Management8 Questions
Exam 25: Laboratory Information Systems32 Questions
Exam 26: Medicolegal and Ethical Aspects of Providing Blood Collection and Transfusion Services27 Questions
Exam 27: Tissue Banking: A New Role for the Transfusion Service10 Questions
Select questions type
How might a technologist detect a patient with drug-induced hemolytic anemia?
(Multiple Choice)
4.9/5
(88)
Which of the following describes the drug-adsorption (Hapten) mechanism?
(Multiple Choice)
4.9/5
(69)
A DAT was performed on a patient suspected of having autoimmune hemolytic anemia. The following results were obtained: PS AHG 3+, Anti-IgG 2+, Anti-C3d-negative. These results mean:
(Multiple Choice)
4.9/5
(88)
Which of the following procedures can be used to resolve interference due to anti-I?
(Multiple Choice)
4.8/5
(75)
Which of the following is a characteristic of autoantibodies?
(Multiple Choice)
4.9/5
(88)
Which of the following can be found in warm autoimmune hemolytic anemia in the presence of hypoplastic marrow?
(Multiple Choice)
4.8/5
(88)
RBCs sensitized in which drug-induced hemolytic anemia mechanism act as "innocent bystanders"?
(Multiple Choice)
4.7/5
(69)
The onset of warm autoimmune hemolytic anemia (WAIHA) may be precipitated by:
(Multiple Choice)
4.9/5
(80)
In the case of an AB-positive individual, what test must be performed to ensure that a warm-reacting autoantibody is not causing false-positive reactions?
(Multiple Choice)
5.0/5
(71)
Which of the following characterizes an alloimmune response in immune hemolytic anemia?
(Multiple Choice)
4.9/5
(81)
How is the serology workup for an autoantibody produced by a drug-induced hemolytic anemia different from other autoantibody workups?
(Multiple Choice)
4.9/5
(83)
All of the following are characteristics of benign cold autoagglutinins except:
(Multiple Choice)
5.0/5
(82)
Autoanti-I was identified in a patient transfused 1 month ago. Which technique is advocated to detect alloantibodies in this patient?
(Multiple Choice)
4.8/5
(85)
Persons diagnosed with pneumonia caused by Mycoplasma pneumoniae may produce a cold autoantibody with___________ specificity.
(Multiple Choice)
4.7/5
(86)
Cold hemagglutinin disease represents what percentage of autoimmune hemolytic anemia (AIHA) cases?
(Multiple Choice)
4.8/5
(84)
Which of the following is a proposed theory for methyldopa-induced mechanism of immune hemolytic anemia?
(Multiple Choice)
4.9/5
(95)
In a patient who has been recently transfused, a positive DAT may be due to:
(Multiple Choice)
4.8/5
(88)
In the digitonin-acid elution procedure, what is the purpose of adding phosphate buffer to the eluate solution?
(Multiple Choice)
4.8/5
(79)
Showing 21 - 40 of 66
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)